The Journal of Immunology, Vol 139, Issue 6 1751-1757, Copyright © 1987 by American Association of Immunologists

ARTICLES

Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement

WM Padberg, RH Lord, JW Kupiec-Weglinski, JM Williams, R Di Stefano, LE Thornburg, D Araneda, TB Strom and NL Tilney

The events leading to immunologic enhancement in LEW rats immunized actively with Brown Norway (BN) rat spleen cells and passively with LEW anti-BN hyperimmune serum 11 and 10 days before receiving (LEW X BN)F1 cardiac allografts, respectively, have been studied. Cellular suppressor mechanisms developing during the induction phase of this phenomenon have recently been shown to be mediated by W3/25+ T cells in an antigen-specific manner. The present study suggests that the late maintenance phase of immunologic enhancement is mediated in vivo by simultaneously present separate donor-specific T cell subpopulations of W3/25+ and OX8+ phenotypes. Splenocyte subsets from grafted recipients greater than 100 days after transplantation were adoptively transferred into unmodified syngeneic LEW rats that received a specific test allograft 24 hr later, or into B recipients bearing indefinitely surviving heart grafts. Test graft survival was prolonged significantly in the first group and not altered in the second. Indeed, nonoverlapping W3/25+ and OX8+ cell fractions were separately responsible for suppression. However, when suppressor activity was tested in vitro in a three-component coculture mixed lymphocyte reaction, no suppression by T cells was obtained; this lack of correlation between in vivo and in vitro results has also been noted by other investigators in different systems. Thus, in the maintenance phase of actively and passively induced immunologic enhancement, interplay between two phenotypically distinct T cells with suppressor characteristics, but not putative cell-surface blocking factors, seems to prevent development of an alloreactive response and mediate host unresponsiveness.

This article has been cited by other articles:

				M. Kataoka, J. A. Margenthaler, G. Ku, and M. W. Flye Development of Infectious Tolerance After Donor-Specific Transfusion and Rat Heart Transplantation J. Immunol., July 1, 2003; 171(1): 204 - 211. [Abstract] [Full Text] [PDF]

				A. Sanchez-Fueyo, M. Weber, C. Domenig, T. B. Strom, and X. X. Zheng Tracking the Immunoregulatory Mechanisms Active During Allograft Tolerance J. Immunol., March 1, 2002; 168(5): 2274 - 2281. [Abstract] [Full Text] [PDF]

				C. Vignes, E. Chiffoleau, P. Douillard, R. Josien, H. Peche, J.-M. Heslan, C. Usal, J.-P. Soulillou, and M. C. Cuturi Anti-TCR-Specific DNA Vaccination Demonstrates a Role for a CD8+ T Cell Clone in the Induction of Allograft Tolerance by Donor-Specific Blood Transfusion J. Immunol., July 1, 2000; 165(1): 96 - 101. [Abstract] [Full Text] [PDF]